Pharmaceuticals
Pharmaceuticals

Accelerating particle size distribution estimation

MIT researchers speed up a novel AI-based estimator for medication manufacturing by 60 times.

MIT-Takeda Program wraps up with 16 publications, a patent, and nearly two dozen projects completed

The program focused on AI in health care, drawing on Takeda’s R&D experience in drug development and MIT’s deep expertise in AI.

A smarter way to streamline drug discovery

The SPARROW algorithm automatically identifies the best molecules to test as potential new medicines, given the vast number of factors affecting each choice.

Symposium highlights scale of mental health crisis and novel methods of diagnosis and treatment

Co-hosted by the McGovern Institute, MIT Open Learning, and others, the symposium stressed emerging technologies in advancing understanding of mental health and neurological conditions.

2023-24 Takeda Fellows: Advancing research at the intersection of AI and health

Thirteen new graduate student fellows will pursue exciting new paths of knowledge and discovery.

Generative AI imagines new protein structures

MIT researchers develop “FrameDiff,” a computational tool that uses generative AI to craft new protein structures, with the aim of accelerating drug development and improving gene therapy.

Novo Nordisk to support MIT postdocs working at the intersection of AI and life sciences

MIT-Novo Nordisk Artificial Intelligence Postdoctoral Fellows Program will support up to 10 postdocs annually over five years.

Researchers develop novel AI-based estimator for manufacturing medicine

A collaborative research team from the MIT-Takeda Program combined physics and machine learning to characterize rough particle surfaces in pharmaceutical pills and powders.

Speeding up drug discovery with diffusion generative models

MIT researchers built DiffDock, a model that may one day be able to find new drugs faster than traditional methods and reduce the potential for adverse side effects.

MIT-Takeda Program heads into fourth year with crop of 10 new projects

The program leverages MIT’s research expertise and Takeda’s industrial know-how for research in artificial intelligence and medicine.